all in one place with Analyst Top Stocks Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter Shanghai Henlius Biotech is moving towards privatization through ...

BEIJING (Reuters) -Cancer treatment specialist BeiGene Ltd plunged 16.4% on its Shanghai debut on Wednesday ... potential U.S. sanctions on Chinese biotech companies. BeiGene, which is already ...

Shanghai, mainland China’s commercial and financial hub, plans to set up a 100 billion yuan (US$13.8 billion) fund of funds focusing on key technology sectors to fire up the local economy, which ...

Shanghai and Shenzhen are shaping up as viable destinations for biotech researchers to raise capital, after they drafted or enacted new rules that match Hong Kong’s overture to pre-revenue ...

There were 7,364 miles stretched between myself and Ming Ma, one of Shanghai’s most exciting young designers, when I called him from New York earlier this week. Yet it felt like he was just down ...

Dr Reddy's Laboratories on Thursday said its subsidiary has inked a licence agreement with Shanghai Henlius Biotech, Inc to develop and commercialise an under-development cancer drug. Dr Reddy's ...

The exhibition "Emperor Yongle's World" kicked off on Friday at the Shanghai-based Long Museum, depicting the peak of the imperial history of the Ming dynasty (1368 AD - 1645 AD) via brilliant ...

No articles found. Diannei (Shanghai) Biotechnology Co., Ltd. did not contribute to any primary research papers from Nature Index journals in the current 12 month window.

SHANGHAI, June 12, 2018 /PRNewswire/ -- Shanghai ChemPartner today announced the appointment of Ming Liu ... the research initiatives of pharma and biotech companies worldwide," said Dr. Liu.

BEIJING, Dec 15 (Reuters) - Cancer treatment specialist BeiGene Ltd plunged 16.4% on its Shanghai debut on Wednesday ... U.S. sanctions on Chinese biotech companies. BeiGene, which is already ...